Literature DB >> 19845571

Coagulation/fibrinolysis and inflammation markers are associated with disease activity in patients with chronic urticaria.

S Takahagi1, S Mihara, K Iwamoto, S Morioke, T Okabe, Y Kameyoshi, M Hide.   

Abstract

BACKGROUND: The evaluation of disease severity and activity of chronic urticaria (CU) is essential for the adequate treatment of patients. However, there is no reliable biomarker for such evaluations. Recently, markers of blood coagulation and fibrinolysis have been revealed to be elevated in severe cases of CU. In this article, we studied the coagulation/fibrinolysis and inflammation markers and their relationship to disease activity in patients with CU.
METHODS: Plasma fibrin degradation products (FDP), d-dimer and serum C-reactive protein (CRP) were measured with the assessment of disease severity and skin reaction to autologous serum in 82 patients with CU and 37 patients with acute urticaria, idiopathic angioedema (AE) or inducible types of urticaria (IU).
RESULTS: The levels of FDP in patients with CU were significantly higher than those in patients with IU, but no other differences in FDP, d-dimer and CRP were observed among patients with different types of urticaria. These markers of patients with CU were well correlated with each other and significantly associated with disease severity of CU, but not with skin reactions to autologous serum. In 37 patients with CU, levels of all these parameters reduced as their disease condition improved, while they increased when the disease became aggravated. Regarding FDP, this relationship was observed even if FDP concentrations were within normal range throughout the study.
CONCLUSIONS: The measurement of plasma FDP, d-dimer and serum CRP may be useful for the assessment of disease activity of CU.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19845571     DOI: 10.1111/j.1398-9995.2009.02222.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  35 in total

1.  Effective treatment of different phenotypes of chronic urticaria with omalizumab: Case reports and review of literature.

Authors:  A Kasperska-Zajac; J Jarząb; A Żerdzińska; K Bąk; A Grzanka
Journal:  Int J Immunopathol Pharmacol       Date:  2016-01-04       Impact factor: 3.219

Review 2.  Mechanisms of action that contribute to efficacy of omalizumab in chronic spontaneous urticaria.

Authors:  A P Kaplan; A M Giménez-Arnau; S S Saini
Journal:  Allergy       Date:  2017-01-04       Impact factor: 13.146

Review 3.  Urticaria and Angioedema: an Update on Classification and Pathogenesis.

Authors:  Susanne Radonjic-Hoesli; Kathrin Scherer Hofmeier; Sara Micaletto; Peter Schmid-Grendelmeier; Andreas Bircher; Dagmar Simon
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

4.  Refractory chronic spontaneous urticaria and permanent atrial fibrillation associated with dental infection: Mere coincidence or something more to it?

Authors:  Alicja Kasperska-Zajac; Alicja Grzanka; Jacek Kowalczyk; Magdalena Wyszyńska-Chłap; Grażyna Lisowska; Jacek Kasperski; Jerzy Jarząb; Maciej Misiołek; Zbigniew Kalarus
Journal:  Int J Immunopathol Pharmacol       Date:  2015-12-03       Impact factor: 3.219

Review 5.  Chronic Urticaria: Advances in Understanding of the Disease and Clinical Management.

Authors:  Liting He; Wanyu Yi; Xin Huang; Hai Long; Qianjin Lu
Journal:  Clin Rev Allergy Immunol       Date:  2021-09-16       Impact factor: 8.667

6.  The role of focal infections in the pathogenesis of psoriasis and chronic urticaria.

Authors:  Paweł Łukasz Brzewski; Magdalena Spałkowska; Magdalena Podbielska; Joanna Chmielewska; Marta Wołek; Katarzyna Malec; Anna Wojas-Pelc
Journal:  Postepy Dermatol Alergol       Date:  2013-04-12       Impact factor: 1.837

7.  Correlation between plasma D-dimer levels and the severity of patients with chronic urticaria.

Authors:  Daranporn Triwongwaranat; Kanokvalai Kulthanan; Leena Chularojanamontri; Samruay Pinkaew
Journal:  Asia Pac Allergy       Date:  2013-04-26

8.  Increased serum complement C3 and C4 concentrations and their relation to severity of chronic spontaneous urticaria and CRP concentration.

Authors:  Alicja Kasperska-Zajac; Alicja Grzanka; Edyta Machura; Maciej Misiolek; Bogdan Mazur; Jerzy Jochem
Journal:  J Inflamm (Lond)       Date:  2013-05-24       Impact factor: 4.981

9.  Analysis of procalcitonin and CRP concentrations in serum of patients with chronic spontaneous urticaria.

Authors:  A Kasperska-Zajac; A Grzanka; E Machura; B Mazur; M Misiolek; E Czecior; J Kasperski; J Jochem
Journal:  Inflamm Res       Date:  2012-12-04       Impact factor: 4.575

10.  Determination of dermatology life quality index, and serum C-reactive protein and plasma interleukin-6 levels in patients with chronic urticaria.

Authors:  Derya Ucmak; Meltem Akkurt; Gülten Toprak; Yavuz Yesilova; Enver Turan; Ismail Yıldız
Journal:  Postepy Dermatol Alergol       Date:  2013-06-20       Impact factor: 1.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.